Acutus Medical (AFIB) Stock Price, News & Analysis

Company Overview

Acutus Medical is a commercial-stage medical technology company specializing in the development and commercialization of advanced cardiac mapping systems designed to improve the diagnosis and treatment of complex cardiac arrhythmias. The company’s flagship product, AcQMap, integrates high-resolution ultrasound imaging with electrical mapping to deliver comprehensive three-dimensional visualizations of arrhythmic sources, aiding electrophysiologists in the targeted management of conditions such as atrial fibrillation.

The AcQMap system employs a noncontact, high-density mapping catheter alongside ultrasound-based anatomical reconstruction to enable rapid, global mapping of cardiac chambers. By capturing electrical and anatomical data concurrently, the technology can reduce procedural times and enhance ablation precision compared with traditional point-by-point mapping approaches. Acutus Medical also provides clinical training, technical support and service programs to help health-care institutions incorporate its mapping solutions into routine electrophysiology workflows.

Founded in 2011 and headquartered in Carlsbad, California, Acutus Medical has secured regulatory clearances including FDA approval in the United States and CE marking in Europe. The company maintains a growing commercial presence across North America and key European markets, serving leading cardiac centers that manage complex arrhythmias. This global footprint reflects Acutus’s focus on expanding access to high-resolution diagnostic tools for atrial and ventricular mapping.

Under the leadership of President and Chief Executive Officer Robert E. White, Acutus Medical has transitioned from a development-stage enterprise to a public company with an emphasis on innovation. The firm continues to invest in research and development initiatives aimed at refining its mapping algorithms and broadening its electrophysiology portfolio, seeking to address a wider range of arrhythmic conditions and enhance overall patient outcomes.

Key Stats

• Today's Range: $0.0004 to $0.0005
• 50-Day Range: N/A
• 52-Week Range: $0.00 to $0.22
• Volume: 4,632 shs
• Average Volume: 35,542 shs
• Market Capitalization: $14.89 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AFIB Stock Analysis - Frequently Asked Questions

How have AFIB shares performed this year?

Acutus Medical's stock was trading at $0.0550 at the beginning of 2025. Since then, AFIB stock has decreased by 99.1% and is now trading at $0.0005.

How were Acutus Medical's earnings last quarter?

Acutus Medical, Inc. (NASDAQ:AFIB) issued its earnings results on Thursday, November, 11th. The company reported ($0.94) earnings per share for the quarter, missing the consensus estimate of ($0.92) by $0.02. The firm earned $4.60 million during the quarter, compared to the consensus estimate of $6.02 million. Acutus Medical had a negative trailing twelve-month return on equity of 311.64% and a negative net margin of 272.74%.

Does Acutus Medical have any subsidiaries?

Acutus Medical subsidiaries include Acutus Medical N.V..

When did Acutus Medical IPO?

Acutus Medical (AFIB) raised $126 million in an initial public offering (IPO) on Thursday, August 6th 2020. The company issued 7,400,000 shares at a price of $16.00-$18.00 per share. J.P. Morgan, BofA Securities and William Blair served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

How do I buy shares of Acutus Medical?

Shares of AFIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Acutus Medical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Acutus Medical investors own include Enterprise Products Partners (EPD), NVIDIA (NVDA), Arista Networks (ANET), Meta Platforms (META), Nextera Energy Partners (NEP), PayPal (PYPL) and Rio Tinto (RIO).

Company Calendar

• Last Earnings: 11/11/2021
• Today: 10/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:AFIB
• CIK: 1522860
• Web: www.acutusmedical.com
• Phone: 442-232-6080
• Fax: 442-232-6081
• Employees: 340
• Year Founded: 2011

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$81.66 million
• Net Margins: -272.74%
• Pretax Margin: -30.32%
• Return on Equity: -311.64%
• Return on Assets: -11.57%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.85
• Quick Ratio: 1.57

Sales & Book Value

• Annual Sales: $7.16 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.03) per share
• Price / Book: -0.02

Miscellaneous

• Outstanding Shares: 29,779,000
• Free Float: 28,228,000
• Market Cap: $14.89 thousand
• Optionable: Optionable
• Beta: -0.67